Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Aug 2015 07:00 AM
RNS
Notice of Interim Results
03 Aug 2015 07:00 AM
RNS
Total Voting Rights
01 Jul 2015 08:54 AM
RNS
Director/PDMR Shareholding
01 Jul 2015 07:00 AM
RNS
Blocklisting Interim Review
01 Jul 2015 07:00 AM
RNS
Total Voting Rights
30 Jun 2015 09:13 AM
RNS
Director/PDMR Shareholding
25 Jun 2015 03:40 PM
RNS
Oxford BioMedica Block listing Application
23 Jun 2015 12:00 PM
RNS
OXB to present at JMP Securities
19 Jun 2015 10:26 AM
RNS
Director/PDMR Shareholding
17 Jun 2015 01:21 PM
RNS
Director/PDMR Shareholding
16 Jun 2015 02:03 PM
RNS
Director/PDMR Shareholding
15 Jun 2015 11:23 AM
RNS
Director/PDMR Shareholding
15 Jun 2015 11:22 AM
RNS
Director/PDMR Shareholding
15 Jun 2015 11:20 AM
RNS
Director/PDMR Shareholding
11 Jun 2015 01:01 PM
RNS
Directors' Interest in Share Options
10 Jun 2015 12:09 PM
RNS
Director/PDMR Shareholding
09 Jun 2015 03:13 PM
RNS
Oxford BioMedica plc Director's Share Purchase
09 Jun 2015 02:56 PM
RNS
Director/PDMR Shareholding
01 Jun 2015 07:00 AM
RNS
Total Voting Rights
22 May 2015 07:00 AM
RNS
Director/PDMR Shareholding
20 May 2015 07:00 AM
RNS
Director/PDMR Shareholding
08 May 2015 07:00 AM
RNS
Deferred Bonus Plan
07 May 2015 01:02 PM
RNS
Result of AGM
07 May 2015 12:37 PM
RNS
Appointment of Non-Executive Director
07 May 2015 07:00 AM
RNS
Interim Management Statement
05 May 2015 07:02 AM
RNS
Summary of ProSavin® data
05 May 2015 07:02 AM
RNS
Presentation of RetinoStat® results
01 May 2015 07:00 AM
RNS
Secures $50 million loan with Oberland Capital
01 May 2015 07:00 AM
RNS
Total Voting Rights
02 Apr 2015 03:40 PM
RNS
2014 Annual Report and Accounts & AGM Notification
01 Apr 2015 04:43 PM
RNS
Holding(s) in Company
01 Apr 2015 12:27 PM
RNS
Oxford BioMedica Total Voting Rights
20 Mar 2015 07:00 AM
RNS
OXB Present at 3rd Annual Regen Med Investor Day
16 Mar 2015 08:59 AM
RNS
Oxford BioMedica plc Director's Share Purchase
13 Mar 2015 07:00 AM
RNS
Preliminary Results
06 Mar 2015 07:00 AM
RNS
Notice of Preliminary Results
05 Mar 2015 09:02 AM
RNS
Announces Presentation at Annual ROTH Conference
03 Mar 2015 07:00 AM
RNS
Credit Suisse's Global Healthcare Conference
03 Mar 2015 07:00 AM
RNS
Total Voting Rights
23 Feb 2015 03:36 PM
RNS
Chief Secretary to the Treasury visits OXB
16 Feb 2015 11:41 AM
RNS
Change of Registered Address
30 Jan 2015 10:47 AM
RNS
Total Voting Rights
28 Jan 2015 04:40 PM
RNS
Second Price Monitoring Extn
28 Jan 2015 04:35 PM
RNS
Price Monitoring Extension
31 Dec 2014 07:00 AM
RNS
BLOCK LISTING RETURN
31 Dec 2014 07:00 AM
RNS
Total Voting Rights
18 Dec 2014 02:45 PM
RNS
Director's Share Purchase.
18 Dec 2014 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16 Dec 2014 03:50 PM
RNS
Director PDMR Shareholding
16 Dec 2014 03:50 PM
RNS
Notification Of Major Interest In Shares

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100